The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis - Top-Institutions - MDSpire

The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis

  • By

  • Yibo Lou

  • Dejun Fan

  • Tiejiang Chen

  • Kai Xiong

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    STAMPEDE
    STAMPEDE

    N/A, N/A

    Key Differentiators

    • Urology

  • #2

    LATITUDE
    LATITUDE

    N/A, N/A

    Key Differentiators

    • Urology

  • #3

    COU-AA-301
    COU-AA-301

    N/A, N/A

    Key Differentiators

    • Urology

  • #4

    COU-AA-302
    COU-AA-302

    N/A, N/A

    Key Differentiators

    • Urology

  • #5

    AFFIRM
    AFFIRM

    N/A, N/A

    Key Differentiators

    • Urology

Original Source(s)

The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis

  • by Yibo Lou, Dejun Fan, Tiejiang Chen, Kai Xiong

  • July 2, 2026

Related Content

LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy

The effect of peer support on fear of disease progression in patients with glioma: a protocol for systematic review and meta-analysis

Identification of key genes potentially associated with bladder cancer development by common plasticizers: an integrated transcriptomics and network toxicology study